![Geoff Oxnard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 331 512 $ am 30.09.2026
Geoff Oxnard is Chief Medical Officer & Executive Vice President at Blossomhill Therapeutics, Inc. since 2025.
Formerly, Dr. Oxnard was Vice President & Global Head-Thoracic Cancers at Eli Lilly & Co. from 2023 to 2025 and Senior Vice President & Head-Clinical Development at F.
Hoffmann-La Roche Ltd. from 2021 to 2023.
Education includes undergraduate studies at Harvard University and a doctorate from Pritzker School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.08.2026 | 17.785 ( 0,06 % ) | 331 512 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2025 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.09.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
